92 Bowery St., New York, NY 10013

+1 800 123 456 789


توقع كل من الشركة المتحدة للتجارة والتوزيع (UCTD) وقسم صحة المستهلك في شركة باير (Bayer) شراكة في السوق المصري

UCTD & Bayer’s Consumer Health Division Sign Partnership in the Egyptian Market

Both companies have signed a contractual agreement to facilitate the import and distribution on a selective set of Bayer’s OTC medicine portfolio.

CAIRO, Egypt – Dr. Mohamed Galal, Vice President & Head of Bayer Consumer Health Division – Middle East, and Mr. Ayman Hossam Omar, Chief Executive Officer of United Company for Trading & Distribution (UCTD), announced the signed-off contract between Bayer’s Consumer Health Division, aiming to import and distribute OTC products in the Egyptian market. This collaborative partnership marks a new strategic alliance with promising prospects and high added value for consumers.

Ayman Hossam stated: “We envision this valuable partnership between the two big companies in the medical manufacturing field (Bayer) and, the distribution field (UCTD) to provide a multitude of benefits to the market and the Egyptian consumers simultaneously”.

The most notable benefit is the availability of Bayer essential products like Becozyme, Bepanthen, Redoxon, Elivit, Rennie, and Clarinase. All these products will always be available and accessible at a huge number of pharmacies in Egypt. These medications will also infiltrate cities and all governorates via the largest distribution network in Egypt, comprised of more than 80 branches in more than 60,000 pharmacies.

Over-the-counter (OTC) medicines play an essential role in keeping consumers and populations healthy with a variety of options while, at the same time driving down healthcare spending. The inclusion of Bayer Consumer health over-the-counter medications will be available too, ensuring its supply to all communities and entities that rely on expertise and capabilities to meet consumers’ needs and ease their wellbeing.

Mr. Ayman Hossam stated, “We are enthusiastic about this collaborative opportunity for both companies to shift the mindset to the difference between OTC and, prescription medications aligning it with the global trends of manufacturing, supplying, and distributing to various markets. This is in addition to building on and expanding the OTC concept as a major goal in addition to the supplying, and distributing of Bayer Consumer Health’s prescription medications already agreed upon”.

“At Bayer’s Consumer Health division, our vision is to make self-care for a better life a reality for billions of people around the world through everyday healthcare. Self-care has never been more important in helping people achieve better health and enabling healthcare systems worldwide to become more sustainable. By providing access to informative tools, resources and knowledge on how to improve people’s daily health – from choosing healthy lifestyles and using consumer products effectively to proper information and self-care learning tools to support appropriate self-diagnosis and self-treatment – we are making a positive impact on the lives of individuals and society as a whole”, added Mohamed Galal.

This is a great opportunity and major milestone for UCTD and Bayer Consumer Health towards a robust alliance aimed at serving the Egyptian healthcare market needs effectively and successfully.

“We are enthusiastic about this collaborative opportunity for both companies to shift the mindset to the difference between OTC and, prescription medications aligning it with the global trends of manufacturing, supplying, and distributing to various markets. This is in addition to building on and expanding the OTC concept as a major goal in addition to the supplying, and distributing of Bayer Consumer Health’s prescription medications already agreed upon” – Mr. Ayman Hossam

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability, and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to

About UCTD

United Company for Trade and Distribution UCTD is the sole agent and importer for several fortune pharmaceutical and FMCG companies in Egypt. Meanwhile, it is the exclusive and/or main distributor of fortune personal care products to the pharmacy market in Egypt. UCTD serves six classes of customers including chain pharmacies, individual pharmacies, wholesalers, hypermarkets, supermarkets, and convenience stores. The company distribution network comprises of 8 regional satellites providing coverage to around 7000 pharmacies 2,890 doors of modern trade, supermarkets, and convenience stores in addition to more than 1100 wholesalers. UCTD distributes more than 4,000 different products supplied by more than 43 vendors. The Company’s strategy calls for focusing its distribution services to the largest 6000 pharmacies through very aggressive key account management for those pharmacies. Meanwhile, leaving the rest of the pharmacies for UCP that provides 100% coverage of all operating pharmacies in Egypt.

Contact for media inquiries:

Reem Hamza

  • United Company of Trading & Distribution
  • Chief Communications Officer
  • Email:
  • Tel.: +201222989830


شراكة بين B-Connect وSupply Chain Junction لتطبيق حلول Manhattan في مصر

B-connect, the electronic arm of H.O Group, announces the starting of a prosperous partnership with Supply Chain Junction (SCJ), the GEO partner for Manhattan associate in Africa and the Middle East.

Accordingly, this partnership positions B-Connect as a services partner for SCJ to ensure the highest level of deployment for Manhattan Associates solutions in Egypt, with vast capabilities and proficient experience in automating and supply chain warehouses of HO Group companies across Egypt.

B-connect also owns a group of experts in logistic warehouses, comprised of the largest technical support team consisting of 150 technical support engineers.



Supply Chain Junction provides best-in-class supply chain software tailored to a wide range of requirements and functions across Africa and the Middle East. Utilizing the Manhattan Associates solution set, SCJ leverages its 20 plus years’ experience and partnership with Manhattan Associates to implement and support warehouse management systems, transportation management systems, order management systems, and omnichannel distribution solutions which provide enable companies to ensure a supply chain advantage.

Ayman Hossam, CEO of H.O Group said “H.O Group is the largest pharmaceutical distributor in Africa and the Middle East, including companies UCP, UCTD and MEC, additionally we own Vetopharm pharmaceutical factory. We have over 15,000 employees, 42% market share and 123 distribution points. Since its inception in the Egyptian market 46 years ago, it has grown to be one of the most trusted and respected brands in the region. We honor our partnership with SCJ to serve our country and implement Manhattan’s Solutions in our newly established pharmaceutical 3PL business through our technical arm, B-Connect.

Michael Badwi, Chief Business Officer of Supply Chain Junction added “We have been servicing Africa and the Middle East since 2002 and are very excited with our partnership with H.O Group through B-Connect, as one of the major leading companies in Egypt. We look forward to supporting and assisting them improve the efficiency of its warehouse operations, optimizing their supply chain and meeting the challenges of shifting consumer expectations”.


حملة التطعيم لجميع العاملين في مجموعة شركات الدكتور حسام عمر (HO GROUP)

Our company takes all precautions to take care of its employees health and wellbeing. Via its human resource department and initiative from Mr. Ayman Hossam stressing the importance of employee health and wellbeing. Consequently, orders were sent out to start vaccinating workers within the HO Group. 

Mr. Ayman believes in taking an active role in protecting and supporting the Egyptian republic along with its workforce. A supportive community is an important pillar in our developmental goals for Egypt 2030. A sentiment also delivered by the president of Egypt as an integral point for Egypt’s social development referred to as the wellbeing and heath of the Egyptian citizen.

Accordingly, Dr. Henady, the HR manager responsible for human affairs for HO group within the middle east branch has issued the order to begin vaccinations for all workers along with their families. Thus the companies management proceeded to communicate with the people responsible within the ministry of health to vaccinate said workforce and their families starting from 14/9/2021

Firstly, we’d like to send a sincere thank you to our president, Mr. Abdel Fattah El Sisi, president of Egypt for his vaccination campaign efforts again the COVID virus.

HO Group as a whole would like to extend its gratitude for everyone responsible for the success of this campaign across many governorates around Egypt, especially the following

  1. Dr. Mrs. Hala Zayed – Minister of Health
  2. Dr. Mohamed Abdel Fattah – Head of Medical Vaccination at the Ministry of Health
  3. Dr. Mohamed Shawky – President of Cairo’s Health Department
  4. All members of the vaccination caravan consisting of doctors and nurses